Zentiva Bucharest facility achieves cost parity with Indian pharmaceutical manufacturing

Zentiva has optimized its Bucharest production site to achieve therapeutic unit costs competitive with Indian manufacturing, facilitating exports to over 30 European markets. The shift highlights a strategic move to localize pharmaceutical supply chains within Europe through automation and cost-efficiency.